The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation

Back

ESC Professional Premium Access

The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation

Session: Prevention of heart failure

Topic: Prevention

Speaker: Doctor S. Shin (Incheon, KR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Sung-Hee Shin

Inha University Hospital, Incheon (Korea (Republic of))

3 presentations

0 follower

5 more presentations in this session

Association of cardiovascular health with incident heart failure in community population without cardiovascular disease: results of the China PEACE million persons project

Speaker: Doctor A. Cai (Guangzhou, CN)

Estimating the extent to which chronic kidney disease mediates the association between metabolic syndrome and heart failure: the Atherosclerosis Risk in Communities (ARIC) Study

Speaker: Doctor C. Ndumele (Baltimore, US)

Hypertension and poor control of systolic blood pressure after a myocardial infarction with non-obstructive coronary arteries are associated with incident heart failure

Speaker: Miss H. Broo (Stockholm, SE)

Open population approach to identify risk factors and detection of cases of heart failure in Mexico

Speaker: Doctor L. Aguilera Mora (Guadalajara, MX)

Improved heart failure screening and prevention in type 2 diabetes mellitus by cardiologist in rural areas

Speaker: Doctor A. Klabnik (Namestovo, SK)

Access the full session

Prevention of heart failure

Speakers: Doctor S. Shin, Doctor A. Cai, Doctor C. Ndumele, Miss H. Broo, Doctor L. Aguilera Mora...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources